Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells
Takeshi Tsuchiya1, Nelson H Tsuno, Masahiro Asakage
1Department of Surgical Oncology, Faculty of Medicine, the University of Tokyo, Tokyo, Japan. tk-tsuchiya@muh.biglobe.ne.jp
Background/Aims:
The p38 mitogen-activated protein kinases (p38 MAPKs) function in a wide variety of signaling pathways. However, the role of p38s is cell type- and stimulus-dependent. The present study aimed to evaluate the effects of p38 MAPK inhibitor on human colon cancer cells.
Methodology:
The effect of p38 MAPK inhibitor, FR167653, on DLD-1 and SW480 was investigated related to cell proliferation, apoptosis induction and caspase activity. Additionally, the effect of FR167653 on colon cancer cell migration, MMPs production and ability to adhere to extracellular matrix was investigated.
Results:
Inhibitor of p38 MAPK dose-dependently suppressed the proliferative activity of both cell lines, and increased the induction of cell apoptosis. The caspase-3, 8, and 9 activities were accompanied in the pathway. Neither cell migration, MMPs production, nor the ability to adhere extracellular matrix were affected by FR167653.
Conclusions:
Inhibitor of p38 MAPK suppressed the proliferation of colon cancer cells by induction of cell apoptosis through the caspase activation. The present results suggest the pro-oncogenic role ofp38 in colon cancer, and its inhibition would be a novel strategy for the prevention and treatment of colon cancer.
Insights
p38 mitogen-activated protein kinases (MAPK) inhibition suppressed colon cancer cell proliferation and induced apoptosis via caspase activation. This suggests p38 MAPK plays a pro-oncogenic role, offering a potential new treatment strategy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- p38 MAPKs are involved in diverse signaling pathways, with context-dependent roles.
- The specific function of p38 MAPKs in colon cancer requires further elucidation.
Purpose of the Study:
- To investigate the impact of a p38 MAPK inhibitor on human colon cancer cell lines.
- To assess the effects on proliferation, apoptosis, and related molecular pathways.
Main Methods:
- Utilized p38 MAPK inhibitor FR167653 on DLD-1 and SW480 colon cancer cells.
- Assessed cell proliferation, apoptosis, caspase activity, migration, MMPs production, and extracellular matrix adhesion.
Main Results:
- FR167653 dose-dependently inhibited colon cancer cell proliferation and increased apoptosis.
- Caspase-3, -8, and -9 activities were modulated, indicating pathway involvement.
- No significant effects were observed on cell migration, MMPs production, or extracellular matrix adhesion.
Conclusions:
- p38 MAPK inhibition effectively suppresses colon cancer cell proliferation through caspase-mediated apoptosis.
- p38 MAPK appears to have a pro-oncogenic role in colon cancer.
- Inhibiting p38 MAPK presents a potential novel therapeutic strategy for colon cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Abnormal Proliferation
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

